-
1
-
-
0027534661
-
Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine
-
Balzarini J., Holy A., Jindrich J., Naesens L., Snoeck R., Schols D., De Clercq E. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrob. Agents Chemother. 1993, 37:332-338.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 332-338
-
-
Balzarini, J.1
Holy, A.2
Jindrich, J.3
Naesens, L.4
Snoeck, R.5
Schols, D.6
De Clercq, E.7
-
2
-
-
0029946597
-
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives
-
Balzarini J., Karlsson A., Aquaro S., Perno C.F., Cahard D., Naesens L., De Clercq E., McGuigan C. Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives. Proc. Natl. Acad. Sci. USA 1996, 93:7295-7299.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 7295-7299
-
-
Balzarini, J.1
Karlsson, A.2
Aquaro, S.3
Perno, C.F.4
Cahard, D.5
Naesens, L.6
De Clercq, E.7
McGuigan, C.8
-
3
-
-
0034806946
-
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults
-
Barditch-Crovo P., Deeks S.G., Collier A., Safrin S., Coakley D.F., Miller M., Kearney B.P., Coleman R.L., Lamy P.D., Kahn J.O., McGowan I., Lietman P.S. Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. Antimicrob. Agents Chemother. 2001, 45:2733-2739.
-
(2001)
Antimicrob. Agents Chemother.
, vol.45
, pp. 2733-2739
-
-
Barditch-Crovo, P.1
Deeks, S.G.2
Collier, A.3
Safrin, S.4
Coakley, D.F.5
Miller, M.6
Kearney, B.P.7
Coleman, R.L.8
Lamy, P.D.9
Kahn, J.O.10
McGowan, I.11
Lietman, P.S.12
-
4
-
-
0035991718
-
Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro
-
Beadle J.R., Hartline C., Aldern K.A., Rodriguez N., Harden E., Kern E.R., Hostetler K.Y. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro. Antimicrob. Agents Chemother. 2002, 46:2381-2386.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 2381-2386
-
-
Beadle, J.R.1
Hartline, C.2
Aldern, K.A.3
Rodriguez, N.4
Harden, E.5
Kern, E.R.6
Hostetler, K.Y.7
-
5
-
-
0034096658
-
Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice
-
Beadle J.R., Kini G.D., Aldern K.A., Gardner M.F., Wright K.N., Rybak R.J., Kern E.R., Hostetler K.Y. Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice. Nucleosides Nucleotides Nucleic Acids 2000, 19:471-479.
-
(2000)
Nucleosides Nucleotides Nucleic Acids
, vol.19
, pp. 471-479
-
-
Beadle, J.R.1
Kini, G.D.2
Aldern, K.A.3
Gardner, M.F.4
Wright, K.N.5
Rybak, R.J.6
Kern, E.R.7
Hostetler, K.Y.8
-
6
-
-
0029731207
-
Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability
-
Benzaria S., Pelicano H., Johnson R., Maury G., Imbach J.L., Aubertin A.M., Obert G., Gosselin G. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability. J. Med. Chem. 1996, 39:4958-4965.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 4958-4965
-
-
Benzaria, S.1
Pelicano, H.2
Johnson, R.3
Maury, G.4
Imbach, J.L.5
Aubertin, A.M.6
Obert, G.7
Gosselin, G.8
-
7
-
-
0022545923
-
Synthesis and antitumor and antiviral properties of 5-alkyl-2'-deoxyuridines, 3',5'-cyclic monophosphates, and neutral cyclic triesters
-
Beres J., Bentrude W.G., Balzarini J., De Clercq E., Otvos L. Synthesis and antitumor and antiviral properties of 5-alkyl-2'-deoxyuridines, 3',5'-cyclic monophosphates, and neutral cyclic triesters. J. Med. Chem. 1986, 29:494-499.
-
(1986)
J. Med. Chem.
, vol.29
, pp. 494-499
-
-
Beres, J.1
Bentrude, W.G.2
Balzarini, J.3
De Clercq, E.4
Otvos, L.5
-
8
-
-
0022481853
-
Synthesis, structure, and antitumor and antiviral activities of a series of 5-halouridine cyclic 3',5'-monophosphates
-
Beres J., Bentrude W.G., Kalman A., Parkanyi L., Balzarini J., De Clercq E. Synthesis, structure, and antitumor and antiviral activities of a series of 5-halouridine cyclic 3',5'-monophosphates. J. Med. Chem. 1986, 29:488-493.
-
(1986)
J. Med. Chem.
, vol.29
, pp. 488-493
-
-
Beres, J.1
Bentrude, W.G.2
Kalman, A.3
Parkanyi, L.4
Balzarini, J.5
De Clercq, E.6
-
9
-
-
0022452139
-
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters
-
Beres J., Sagi G., Bentrude W.G., Balzarini J., De Clercq E., Otvos L. Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. J. Med. Chem. 1986, 29:1243-1249.
-
(1986)
J. Med. Chem.
, vol.29
, pp. 1243-1249
-
-
Beres, J.1
Sagi, G.2
Bentrude, W.G.3
Balzarini, J.4
De Clercq, E.5
Otvos, L.6
-
10
-
-
0026524094
-
Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial
-
Berk L., Schalm S.W., de Man R.A., Heytink R.A., Berthelot P., Brechot C., Boboc B., Degos F., Marcellin P., Benhamou J.P., et al. Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial. J. Hepatol. 1992, 14:305-309.
-
(1992)
J. Hepatol.
, vol.14
, pp. 305-309
-
-
Berk, L.1
Schalm, S.W.2
de Man, R.A.3
Heytink, R.A.4
Berthelot, P.5
Brechot, C.6
Boboc, B.7
Degos, F.8
Marcellin, P.9
Benhamou, J.P.10
-
11
-
-
45749091322
-
Activation of 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino] phenoxyphosphinyl]-methoxy]propyl]adenine (GS-7340) and other tenofovir phosphonoamidate prodrugs by human proteases
-
Birkus G., Kutty N., He G.X., Mulato A., Lee W., McDermott M., Cihlar T. Activation of 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino] phenoxyphosphinyl]-methoxy]propyl]adenine (GS-7340) and other tenofovir phosphonoamidate prodrugs by human proteases. Mol. Pharmacol. 2008, 74:92-100.
-
(2008)
Mol. Pharmacol.
, vol.74
, pp. 92-100
-
-
Birkus, G.1
Kutty, N.2
He, G.X.3
Mulato, A.4
Lee, W.5
McDermott, M.6
Cihlar, T.7
-
12
-
-
33846690778
-
Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131
-
Birkus G., Wang R., Liu X., Kutty N., MacArthur H., Cihlar T., Gibbs C., Swaminathan S., Lee W., McDermott M. Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131. Antimicrob. Agents Chemother. 2007, 51:543-550.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 543-550
-
-
Birkus, G.1
Wang, R.2
Liu, X.3
Kutty, N.4
MacArthur, H.5
Cihlar, T.6
Gibbs, C.7
Swaminathan, S.8
Lee, W.9
McDermott, M.10
-
13
-
-
0027980318
-
1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo
-
Bischofberger N., Hitchcock M.J., Chen M.S., Barkhimer D.B., Cundy K.C., Kent K.M., Lacy S.A., Lee W.A., Li Z.H., Mendel D.B., et al. 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo. Antimicrob. Agents Chemother. 1994, 38:2387-2391.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 2387-2391
-
-
Bischofberger, N.1
Hitchcock, M.J.2
Chen, M.S.3
Barkhimer, D.B.4
Cundy, K.C.5
Kent, K.M.6
Lacy, S.A.7
Lee, W.A.8
Li, Z.H.9
Mendel, D.B.10
-
14
-
-
78651110499
-
Advances in nucleoside monophosphate prodrugs as anti-HCV agents
-
Bobeck D.R., Schinazi R.F., Coats S.J. Advances in nucleoside monophosphate prodrugs as anti-HCV agents. Antiviral Ther. 2010, 15:935-950.
-
(2010)
Antiviral Ther.
, vol.15
, pp. 935-950
-
-
Bobeck, D.R.1
Schinazi, R.F.2
Coats, S.J.3
-
15
-
-
0031451851
-
Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290)
-
Bogner J.R., Boerner D., Muhlhofer A., Thoma-Greber E., Herrmann D.B., Hoegl L., Roecken M., Jost V., Goebel F.D. Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290). Antiviral Ther 1997, 2:249-256.
-
(1997)
Antiviral Ther
, vol.2
, pp. 249-256
-
-
Bogner, J.R.1
Boerner, D.2
Muhlhofer, A.3
Thoma-Greber, E.4
Herrmann, D.B.5
Hoegl, L.6
Roecken, M.7
Jost, V.8
Goebel, F.D.9
-
16
-
-
0031282842
-
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial
-
Bogner J.R., Roecken M., Herrmann D.B., Boerner D., Kaufmann B., Gurtler L., Plewig G., Goebel F.D. Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial. Antiviral Ther 1997, 2:257-264.
-
(1997)
Antiviral Ther
, vol.2
, pp. 257-264
-
-
Bogner, J.R.1
Roecken, M.2
Herrmann, D.B.3
Boerner, D.4
Kaufmann, B.5
Gurtler, L.6
Plewig, G.7
Goebel, F.D.8
-
17
-
-
0030049336
-
Potential lipophilic nucleotide prodrugs: synthesis, hydrolysis, and antiretroviral activity of AZT and d4T acyl nucleotides
-
Bonnaffe D., Dupraz B., Ughetto-Monfrin J., Namane A., Henin Y., Huynh-Dinh T. Potential lipophilic nucleotide prodrugs: synthesis, hydrolysis, and antiretroviral activity of AZT and d4T acyl nucleotides. J. Org. Chem. 1996, 61:895-902.
-
(1996)
J. Org. Chem.
, vol.61
, pp. 895-902
-
-
Bonnaffe, D.1
Dupraz, B.2
Ughetto-Monfrin, J.3
Namane, A.4
Henin, Y.5
Huynh-Dinh, T.6
-
18
-
-
0036890172
-
Pivalate-generating prodrugs and carnitine homeostasis in man
-
Brass E.P. Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol. Rev. 2002, 54:589-598.
-
(2002)
Pharmacol. Rev.
, vol.54
, pp. 589-598
-
-
Brass, E.P.1
-
19
-
-
73549103358
-
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
-
Broder S. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res. 2010, 85:1-18.
-
(2010)
Antiviral Res.
, vol.85
, pp. 1-18
-
-
Broder, S.1
-
21
-
-
2342589409
-
Strategies in the design of prodrugs of anti-HIV agents
-
Calogeropoulou T., Detsi A., Lekkas E., Koufaki M. Strategies in the design of prodrugs of anti-HIV agents. Curr. Top. Med. Chem. 2003, 3:1467-1495.
-
(2003)
Curr. Top. Med. Chem.
, vol.3
, pp. 1467-1495
-
-
Calogeropoulou, T.1
Detsi, A.2
Lekkas, E.3
Koufaki, M.4
-
22
-
-
0028833056
-
Synthesis and anti-HIV evaluation of alkyl and alkoxyethyl phosphodiester AZT derivatives
-
Calogeropoulou T., Koufaki M., Tsotinis A., De Clercq E., Makriyannis A. Synthesis and anti-HIV evaluation of alkyl and alkoxyethyl phosphodiester AZT derivatives. Antiviral Chem. Chemother. 1995, 6:43-49.
-
(1995)
Antiviral Chem. Chemother.
, vol.6
, pp. 43-49
-
-
Calogeropoulou, T.1
Koufaki, M.2
Tsotinis, A.3
De Clercq, E.4
Makriyannis, A.5
-
23
-
-
79951544544
-
Discovery of PSI-353661, a novel purine nucleotide prodrug for the treatment of HCV infection
-
Chang W., Bao D., Chun B.K., Naduthambi D., Nagarathnam D., Rachakonda S., Reddy P.G., Ross B.S., Zhang H.R., Bansal S., Espiritu C., Keilman M., Lam A.M., Niu C., Steuer H.M., Furman P.A., Otto M.J., Sofia M.J. Discovery of PSI-353661, a novel purine nucleotide prodrug for the treatment of HCV infection. ACS Med. Chem. Lett. 2011, 2:130-135.
-
(2011)
ACS Med. Chem. Lett.
, vol.2
, pp. 130-135
-
-
Chang, W.1
Bao, D.2
Chun, B.K.3
Naduthambi, D.4
Nagarathnam, D.5
Rachakonda, S.6
Reddy, P.G.7
Ross, B.S.8
Zhang, H.R.9
Bansal, S.10
Espiritu, C.11
Keilman, M.12
Lam, A.M.13
Niu, C.14
Steuer, H.M.15
Furman, P.A.16
Otto, M.J.17
Sofia, M.J.18
-
24
-
-
78649937348
-
Development of cytarabine prodrugs and delivery systems for leukemia treatment
-
Chhikara B.S., Parang K. Development of cytarabine prodrugs and delivery systems for leukemia treatment. Expert Opin. Drug Deliv. 2010, 7:1399-1414.
-
(2010)
Expert Opin. Drug Deliv.
, vol.7
, pp. 1399-1414
-
-
Chhikara, B.S.1
Parang, K.2
-
25
-
-
2442661557
-
A novel class of phosphonate nucleosides. 9-[(1-phosphonomethoxycyclopropyl)methyl]guanine as a potent and selective anti-HBV agent
-
Choi J.R., Cho D.G., Roh K.Y., Hwang J.T., Ahn S., Jang H.S., Cho W.Y., Kim K.W., Cho Y.G., Kim J., Kim Y.Z. A novel class of phosphonate nucleosides. 9-[(1-phosphonomethoxycyclopropyl)methyl]guanine as a potent and selective anti-HBV agent. J. Med. Chem. 2004, 47:2864-2869.
-
(2004)
J. Med. Chem.
, vol.47
, pp. 2864-2869
-
-
Choi, J.R.1
Cho, D.G.2
Roh, K.Y.3
Hwang, J.T.4
Ahn, S.5
Jang, H.S.6
Cho, W.Y.7
Kim, K.W.8
Cho, Y.G.9
Kim, J.10
Kim, Y.Z.11
-
26
-
-
34247380394
-
Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins
-
Chou T.F., Baraniak J., Kaczmarek R., Zhou X., Cheng J., Ghosh B., Wagner C.R. Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins. Mol. Pharm. 2007, 4:208-217.
-
(2007)
Mol. Pharm.
, vol.4
, pp. 208-217
-
-
Chou, T.F.1
Baraniak, J.2
Kaczmarek, R.3
Zhou, X.4
Cheng, J.5
Ghosh, B.6
Wagner, C.R.7
-
27
-
-
73549088038
-
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
-
Cihlar T., Ray A.S. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antiviral Res. 2010, 85:39-58.
-
(2010)
Antiviral Res.
, vol.85
, pp. 39-58
-
-
Cihlar, T.1
Ray, A.S.2
-
28
-
-
38649089790
-
Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131
-
Cihlar T., Ray A.S., Boojamra C.G., Zhang L., Hui H., Laflamme G., Vela J.E., Grant D., Chen J., Myrick F., White K.L., Gao Y., Lin K.Y., Douglas J.L., Parkin N.T., Carey A., Pakdaman R., Mackman R.L. Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131. Antimicrob. Agents Chemother. 2008, 52:655-665.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 655-665
-
-
Cihlar, T.1
Ray, A.S.2
Boojamra, C.G.3
Zhang, L.4
Hui, H.5
Laflamme, G.6
Vela, J.E.7
Grant, D.8
Chen, J.9
Myrick, F.10
White, K.L.11
Gao, Y.12
Lin, K.Y.13
Douglas, J.L.14
Parkin, N.T.15
Carey, A.16
Pakdaman, R.17
Mackman, R.L.18
-
29
-
-
0016792704
-
Tumor-inhibiting properties of the neutral P-O-ethyl ester of adenosine 3':5'-monophosphate in correlation with its crystal and molecular structure
-
Cotton F.A., Gillen R.G., Gohil R.N., Hazen E.E., Kirchner C.R., Nagyvary J., Rouse J.P., Stanislowski A.G., Stevens J.D., Tucker P.W. Tumor-inhibiting properties of the neutral P-O-ethyl ester of adenosine 3':5'-monophosphate in correlation with its crystal and molecular structure. Proc. Natl. Acad. Sci. USA 1975, 72:1335-1339.
-
(1975)
Proc. Natl. Acad. Sci. USA
, vol.72
, pp. 1335-1339
-
-
Cotton, F.A.1
Gillen, R.G.2
Gohil, R.N.3
Hazen, E.E.4
Kirchner, C.R.5
Nagyvary, J.6
Rouse, J.P.7
Stanislowski, A.G.8
Stevens, J.D.9
Tucker, P.W.10
-
30
-
-
0033039933
-
Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients
-
Cundy K.C., Barditch-Crovo P., Petty B.G., Ruby A., Redpath M., Jaffe H.S., Lietman P.S. Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 1999, 43:271-277.
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, pp. 271-277
-
-
Cundy, K.C.1
Barditch-Crovo, P.2
Petty, B.G.3
Ruby, A.4
Redpath, M.5
Jaffe, H.S.6
Lietman, P.S.7
-
31
-
-
0025609122
-
Synthesis and anti-HIV evaluation of some phosphoramidate derivatives of AZT: studies on the effect of chain elongation on biological activity
-
Curley D., McGuigan C., Devine K.G., O'Connor T.J., Jeffries D.J., Kinchington D. Synthesis and anti-HIV evaluation of some phosphoramidate derivatives of AZT: studies on the effect of chain elongation on biological activity. Antiviral Res. 1990, 14:345-356.
-
(1990)
Antiviral Res.
, vol.14
, pp. 345-356
-
-
Curley, D.1
McGuigan, C.2
Devine, K.G.3
O'Connor, T.J.4
Jeffries, D.J.5
Kinchington, D.6
-
32
-
-
30344486584
-
Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy
-
De Clercq E., Field H.J. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy. Br. J. Pharmacol. 2006, 147:1-11.
-
(2006)
Br. J. Pharmacol.
, vol.147
, pp. 1-11
-
-
De Clercq, E.1
Field, H.J.2
-
33
-
-
0022450584
-
A novel selective broad-spectrum anti-DNA virus agent
-
De Clercq E., Holy A., Rosenberg I., Sakuma T., Balzarini J., Maudgal P.C. A novel selective broad-spectrum anti-DNA virus agent. Nature 1986, 323:464-467.
-
(1986)
Nature
, vol.323
, pp. 464-467
-
-
De Clercq, E.1
Holy, A.2
Rosenberg, I.3
Sakuma, T.4
Balzarini, J.5
Maudgal, P.C.6
-
34
-
-
0023607245
-
Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines
-
De Clercq E., Sakuma T., Baba M., Pauwels R., Balzarini J., Rosenberg I., Holy A. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. Antiviral Res. 1987, 8:261-272.
-
(1987)
Antiviral Res.
, vol.8
, pp. 261-272
-
-
De Clercq, E.1
Sakuma, T.2
Baba, M.3
Pauwels, R.4
Balzarini, J.5
Rosenberg, I.6
Holy, A.7
-
35
-
-
0031710248
-
Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults
-
Deeks S.G., Barditch-Crovo P., Lietman P.S., Hwang F., Cundy K.C., Rooney J.F., Hellmann N.S., Safrin S., Kahn J.O. Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults. Antimicrob. Agents Chemother. 1998, 42:2380-2384.
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 2380-2384
-
-
Deeks, S.G.1
Barditch-Crovo, P.2
Lietman, P.S.3
Hwang, F.4
Cundy, K.C.5
Rooney, J.F.6
Hellmann, N.S.7
Safrin, S.8
Kahn, J.O.9
-
36
-
-
0025220368
-
Novel phosphate derivatives of zidovudine as anti-HIV compounds
-
Devine K.G., McGuigan C., O'Connor T.J., Nicholls S.R., Kinchington D. Novel phosphate derivatives of zidovudine as anti-HIV compounds. AIDS (London, England) 1990, 4:371-373.
-
(1990)
AIDS (London, England)
, vol.4
, pp. 371-373
-
-
Devine, K.G.1
McGuigan, C.2
O'Connor, T.J.3
Nicholls, S.R.4
Kinchington, D.5
-
37
-
-
60749111167
-
Synthesis and evaluation of novel phosphoramidate prodrugs of 2'-methyl cytidine as inhibitors of hepatitis C virus NS5B polymerase
-
Donghi M., Attenni B., Gardelli C., Marco A.D., Fiore F., Giuliano C., Laufer R., Leone J.F., Pucci V., Rowley M., Narjes F. Synthesis and evaluation of novel phosphoramidate prodrugs of 2'-methyl cytidine as inhibitors of hepatitis C virus NS5B polymerase. Bioorg. Med. Chem. Lett. 2009, 19:1392-1395.
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 1392-1395
-
-
Donghi, M.1
Attenni, B.2
Gardelli, C.3
Marco, A.D.4
Fiore, F.5
Giuliano, C.6
Laufer, R.7
Leone, J.F.8
Pucci, V.9
Rowley, M.10
Narjes, F.11
-
38
-
-
68249104931
-
Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys
-
Durand-Gasselin L., Van Rompay K.K., Vela J.E., Henne I.N., Lee W.A., Rhodes G.R., Ray A.S. Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys. Mol. Pharm. 2009, 6:1145-1151.
-
(2009)
Mol. Pharm.
, vol.6
, pp. 1145-1151
-
-
Durand-Gasselin, L.1
Van Rompay, K.K.2
Vela, J.E.3
Henne, I.N.4
Lee, W.A.5
Rhodes, G.R.6
Ray, A.S.7
-
39
-
-
0141923630
-
S-Acyl-2-thioethyl phosphoramidate diester derivatives as mononucleotide prodrugs
-
Egron D., Imbach J.L., Gosselin G., Aubertin A.M., Perigaud C. S-Acyl-2-thioethyl phosphoramidate diester derivatives as mononucleotide prodrugs. J. Med. Chem. 2003, 46:4564-4571.
-
(2003)
J. Med. Chem.
, vol.46
, pp. 4564-4571
-
-
Egron, D.1
Imbach, J.L.2
Gosselin, G.3
Aubertin, A.M.4
Perigaud, C.5
-
40
-
-
0034839526
-
Synthesis and study of a new series of phosphoramidate derivatives as mononucleotide prodrugs
-
Egron D., Perigaud C., Gosselin G., Aubertin A.M., Imbach J.L. Synthesis and study of a new series of phosphoramidate derivatives as mononucleotide prodrugs. Nucleosides Nucleotides Nucleic Acids 2001, 20:751-754.
-
(2001)
Nucleosides Nucleotides Nucleic Acids
, vol.20
, pp. 751-754
-
-
Egron, D.1
Perigaud, C.2
Gosselin, G.3
Aubertin, A.M.4
Imbach, J.L.5
-
41
-
-
0034852392
-
Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood
-
Eisenberg E.J., He G.X., Lee W.A. Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood. Nucleosides Nucleotides Nucleic Acids 2001, 20:1091-1098.
-
(2001)
Nucleosides Nucleotides Nucleic Acids
, vol.20
, pp. 1091-1098
-
-
Eisenberg, E.J.1
He, G.X.2
Lee, W.A.3
-
42
-
-
51049110960
-
Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity
-
Eriksson U., Peterson L.W., Kashemirov B.A., Hilfinger J.M., Drach J.C., Borysko K.Z., Breitenbach J.M., Kim J.S., Mitchell S., Kijek P., McKenna C.E. Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity. Mol. Pharm. 2008, 5:598-609.
-
(2008)
Mol. Pharm.
, vol.5
, pp. 598-609
-
-
Eriksson, U.1
Peterson, L.W.2
Kashemirov, B.A.3
Hilfinger, J.M.4
Drach, J.C.5
Borysko, K.Z.6
Breitenbach, J.M.7
Kim, J.S.8
Mitchell, S.9
Kijek, P.10
McKenna, C.E.11
-
43
-
-
32544443162
-
HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver
-
Erion M.D., Bullough D.A., Lin C.C., Hong Z. HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver. Curr. Opin. Investig. Drugs 2006, 7:109-117.
-
(2006)
Curr. Opin. Investig. Drugs
, vol.7
, pp. 109-117
-
-
Erion, M.D.1
Bullough, D.A.2
Lin, C.C.3
Hong, Z.4
-
44
-
-
11144357250
-
Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver
-
Erion M.D., Reddy K.R., Boyer S.H., Matelich M.C., Gomez-Galeno J., Lemus R.H., Ugarkar B.G., Colby T.J., Schanzer J., Van Poelje P.D. Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver. J. Am. Chem. Soc. 2004, 126:5154-5163.
-
(2004)
J. Am. Chem. Soc.
, vol.126
, pp. 5154-5163
-
-
Erion, M.D.1
Reddy, K.R.2
Boyer, S.H.3
Matelich, M.C.4
Gomez-Galeno, J.5
Lemus, R.H.6
Ugarkar, B.G.7
Colby, T.J.8
Schanzer, J.9
Van Poelje, P.D.10
-
45
-
-
0020676398
-
Biologically reversible phosphate-protective groups
-
Farquhar D., Srivastva D.N., Kattesch N.J., Saunders P.P. Biologically reversible phosphate-protective groups. J. Pharm. Sci. 1983, 72:324-325.
-
(1983)
J. Pharm. Sci.
, vol.72
, pp. 324-325
-
-
Farquhar, D.1
Srivastva, D.N.2
Kattesch, N.J.3
Saunders, P.P.4
-
46
-
-
0022357014
-
Preparation of a lactosaminated albumin-ara-AMP conjugate which remains soluble after lyophilization
-
Fiume L., Bassi B., Busi C., Mattioli A. Preparation of a lactosaminated albumin-ara-AMP conjugate which remains soluble after lyophilization. Pharm. Acta. Helv. 1985, 60:318-320.
-
(1985)
Pharm. Acta. Helv.
, vol.60
, pp. 318-320
-
-
Fiume, L.1
Bassi, B.2
Busi, C.3
Mattioli, A.4
-
47
-
-
0022996630
-
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase
-
Furman P.A., Fyfe J.A., St Clair M.H., Weinhold K., Rideout J.L., Freeman G.A., Lehrman S.N., Bolognesi D.P., Broder S., Mitsuya H., et al. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 1986, 83:8333-8337.
-
(1986)
Proc. Natl. Acad. Sci. USA
, vol.83
, pp. 8333-8337
-
-
Furman, P.A.1
Fyfe, J.A.2
St Clair, M.H.3
Weinhold, K.4
Rideout, J.L.5
Freeman, G.A.6
Lehrman, S.N.7
Bolognesi, D.P.8
Broder, S.9
Mitsuya, H.10
-
48
-
-
79958255214
-
Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661
-
Furman P.A., Murakami E., Niu C., Lam A.M., Espiritu C., Bansal S., Bao H., Tolstykh T., Micolochick Steuer H., Keilman M., Zennou V., Bourne N., Veselenak R.L., Chang W., Ross B.S., Du J., Otto M.J., Sofia M.J. Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661. Antiviral Res. 2011, 91:120-132.
-
(2011)
Antiviral Res.
, vol.91
, pp. 120-132
-
-
Furman, P.A.1
Murakami, E.2
Niu, C.3
Lam, A.M.4
Espiritu, C.5
Bansal, S.6
Bao, H.7
Tolstykh, T.8
Micolochick Steuer, H.9
Keilman, M.10
Zennou, V.11
Bourne, N.12
Veselenak, R.L.13
Chang, W.14
Ross, B.S.15
Du, J.16
Otto, M.J.17
Sofia, M.J.18
-
49
-
-
69949103162
-
Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection
-
Gardelli C., Attenni B., Donghi M., Meppen M., Pacini B., Harper S., Di Marco A., Fiore F., Giuliano C., Pucci V., Laufer R., Gennari N., Marcucci I., Leone J.F., Olsen D.B., MacCoss M., Rowley M., Narjes F. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection. J. Med. Chem. 2009, 52:5394-5407.
-
(2009)
J. Med. Chem.
, vol.52
, pp. 5394-5407
-
-
Gardelli, C.1
Attenni, B.2
Donghi, M.3
Meppen, M.4
Pacini, B.5
Harper, S.6
Di Marco, A.7
Fiore, F.8
Giuliano, C.9
Pucci, V.10
Laufer, R.11
Gennari, N.12
Marcucci, I.13
Leone, J.F.14
Olsen, D.B.15
MacCoss, M.16
Rowley, M.17
Narjes, F.18
-
50
-
-
0034162182
-
Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy
-
Girard P.M., Pegram P.S., Diquet B., Anderson R., Raffi F., Tubiana R., Sereni D., Boerner D. Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy. J. Acquir. Immune Defic. Syndr. 2000, 23:227-235.
-
(2000)
J. Acquir. Immune Defic. Syndr.
, vol.23
, pp. 227-235
-
-
Girard, P.M.1
Pegram, P.S.2
Diquet, B.3
Anderson, R.4
Raffi, F.5
Tubiana, R.6
Sereni, D.7
Boerner, D.8
-
51
-
-
34147154785
-
Enzymatically activated cycloSal-d4T-monophosphates: the third generation of cycloSal-pronucleotides
-
Gisch N., Balzarini J., Meier C. Enzymatically activated cycloSal-d4T-monophosphates: the third generation of cycloSal-pronucleotides. J. Med. Chem. 2007, 50:1658-1667.
-
(2007)
J. Med. Chem.
, vol.50
, pp. 1658-1667
-
-
Gisch, N.1
Balzarini, J.2
Meier, C.3
-
52
-
-
66749116603
-
Doubly loaded cycloSaligenyl-pronucleotides - 5,5'-Bis-(cycloSaligenyl-2',3'-dideoxy-2',3'-didehydrothymidine monophosphates)
-
Gisch N., Balzarini J., Meier C. Doubly loaded cycloSaligenyl-pronucleotides - 5,5'-Bis-(cycloSaligenyl-2',3'-dideoxy-2',3'-didehydrothymidine monophosphates). J. Med. Chem. 2009, 52:3464-3473.
-
(2009)
J. Med. Chem.
, vol.52
, pp. 3464-3473
-
-
Gisch, N.1
Balzarini, J.2
Meier, C.3
-
53
-
-
0016180458
-
Synthesis and properties of some cyclic AMP alkyl phosphotriesters
-
Gohil R.N., Gillen R.G., Nagyvary J. Synthesis and properties of some cyclic AMP alkyl phosphotriesters. Nucleic Acids Res. 1974, 1:1691-1701.
-
(1974)
Nucleic Acids Res.
, vol.1
, pp. 1691-1701
-
-
Gohil, R.N.1
Gillen, R.G.2
Nagyvary, J.3
-
54
-
-
0003149806
-
New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy
-
Gosselin G., Girardet J.L., Perigaud C., Benzaria S., Lefebvre I., Schlienger N., Pompon A., Imbach J.L. New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy. Acta. Biochim. Pol. 1996, 43:196-208.
-
(1996)
Acta. Biochim. Pol.
, vol.43
, pp. 196-208
-
-
Gosselin, G.1
Girardet, J.L.2
Perigaud, C.3
Benzaria, S.4
Lefebvre, I.5
Schlienger, N.6
Pompon, A.7
Imbach, J.L.8
-
55
-
-
0024426186
-
6- and 1-Substituted mannosyl phosphotryiesters as lipophilic macrophage-targeted carriers of aniviral nucleosides
-
Gouyette C., Neumann J.M., Fauve R., Huynh-Dinh T. 6- and 1-Substituted mannosyl phosphotryiesters as lipophilic macrophage-targeted carriers of aniviral nucleosides. Tetrahedron Lett. 1989, 30:6019-6022.
-
(1989)
Tetrahedron Lett.
, vol.30
, pp. 6019-6022
-
-
Gouyette, C.1
Neumann, J.M.2
Fauve, R.3
Huynh-Dinh, T.4
-
56
-
-
33947723257
-
Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication
-
Gunic E., Girardet J.L., Ramasamy K., Stoisavljevic-Petkov V., Chow S., Yeh L.T., Hamatake R.K., Raney A., Hong Z. Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication. Bioorg. Med. Chem. Lett. 2007, 17:2452-2455.
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 2452-2455
-
-
Gunic, E.1
Girardet, J.L.2
Ramasamy, K.3
Stoisavljevic-Petkov, V.4
Chow, S.5
Yeh, L.T.6
Hamatake, R.K.7
Raney, A.8
Hong, Z.9
-
57
-
-
0021208982
-
Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2'-deoxyuridine
-
Hantz O., Allaudeen H.S., Ooka T., De Clercq E., Trepo C. Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2'-deoxyuridine. Antiviral Res. 1984, 4:187-199.
-
(1984)
Antiviral Res.
, vol.4
, pp. 187-199
-
-
Hantz, O.1
Allaudeen, H.S.2
Ooka, T.3
De Clercq, E.4
Trepo, C.5
-
58
-
-
43049112098
-
Prodrugs of phosphates and phosphonates
-
Hecker S.J., Erion M.D. Prodrugs of phosphates and phosphonates. J. Med. Chem. 2008, 51:2328-2345.
-
(2008)
J. Med. Chem.
, vol.51
, pp. 2328-2345
-
-
Hecker, S.J.1
Erion, M.D.2
-
59
-
-
34548097065
-
Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection
-
Hecker S.J., Reddy K.R., van Poelje P.D., Sun Z., Huang W., Varkhedkar V., Reddy M.V., Fujitaki J.M., Olsen D.B., Koeplinger K.A., Boyer S.H., Linemeyer D.L., MacCoss M., Erion M.D. Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection. J. Med. Chem. 2007, 50:3891-3896.
-
(2007)
J. Med. Chem.
, vol.50
, pp. 3891-3896
-
-
Hecker, S.J.1
Reddy, K.R.2
van Poelje, P.D.3
Sun, Z.4
Huang, W.5
Varkhedkar, V.6
Reddy, M.V.7
Fujitaki, J.M.8
Olsen, D.B.9
Koeplinger, K.A.10
Boyer, S.H.11
Linemeyer, D.L.12
MacCoss, M.13
Erion, M.D.14
-
60
-
-
0025814856
-
Lipophilic glycosyl phosphotriester derivatives of AZT: synthesis, NMR transmembrane transport study, and antiviral activity
-
Henin Y., Gouyette C., Schwartz O., Debouzy J.C., Neumann J.M., Huynh-Dinh T. Lipophilic glycosyl phosphotriester derivatives of AZT: synthesis, NMR transmembrane transport study, and antiviral activity. J. Med. Chem. 1991, 34:1830-1837.
-
(1991)
J. Med. Chem.
, vol.34
, pp. 1830-1837
-
-
Henin, Y.1
Gouyette, C.2
Schwartz, O.3
Debouzy, J.C.4
Neumann, J.M.5
Huynh-Dinh, T.6
-
62
-
-
67349157073
-
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art
-
Hostetler K.Y. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. Antiviral Res. 2009, 82:A84-A98.
-
(2009)
Antiviral Res.
, vol.82
-
-
Hostetler, K.Y.1
-
63
-
-
79952147366
-
Synthesis and early development of hexadecyloxypropyl-cidofovir: an oral antipoxvirus nucleoside phosphonate
-
Hostetler K.Y. Synthesis and early development of hexadecyloxypropyl-cidofovir: an oral antipoxvirus nucleoside phosphonate. Viruses 2010, 2:2213-2225.
-
(2010)
Viruses
, vol.2
, pp. 2213-2225
-
-
Hostetler, K.Y.1
-
64
-
-
0033917391
-
Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infection
-
Hostetler K.Y., Beadle J.R., Hornbuckle W.E., Bellezza C.A., Tochkov I.A., Cote P.J., Gerin J.L., Korba B.E., Tennant B.C. Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob. Agents Chemother. 2000, 44:1964-1969.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 1964-1969
-
-
Hostetler, K.Y.1
Beadle, J.R.2
Hornbuckle, W.E.3
Bellezza, C.A.4
Tochkov, I.A.5
Cote, P.J.6
Gerin, J.L.7
Korba, B.E.8
Tennant, B.C.9
-
65
-
-
0030786518
-
Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro
-
Hostetler K.Y., Beadle J.R., Kini G.D., Gardner M.F., Wright K.N., Wu T.H., Korba B.A. Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro. Biochem. Pharmacol. 1997, 53:1815-1822.
-
(1997)
Biochem. Pharmacol.
, vol.53
, pp. 1815-1822
-
-
Hostetler, K.Y.1
Beadle, J.R.2
Kini, G.D.3
Gardner, M.F.4
Wright, K.N.5
Wu, T.H.6
Korba, B.A.7
-
66
-
-
0025955435
-
Phosphatidylazidothymidine. Mechanism of antiretroviral action in CEM cells
-
Hostetler K.Y., Carson D.A., Richman D.D. Phosphatidylazidothymidine. Mechanism of antiretroviral action in CEM cells. J. Biol. Chem. 1991, 266:11714-11717.
-
(1991)
J. Biol. Chem.
, vol.266
, pp. 11714-11717
-
-
Hostetler, K.Y.1
Carson, D.A.2
Richman, D.D.3
-
67
-
-
0027136229
-
Acyclovir diphosphate dimyristoylglycerol: a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus
-
Hostetler K.Y., Parker S., Sridhar C.N., Martin M.J., Li J.L., Stuhmiller L.M., van Wijk G.M., van den Bosch H., Gardner M.F., Aldern K.A., et al. Acyclovir diphosphate dimyristoylglycerol: a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus. Proc. Natl. Acad. Sci. USA 1993, 90:11835-11839.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 11835-11839
-
-
Hostetler, K.Y.1
Parker, S.2
Sridhar, C.N.3
Martin, M.J.4
Li, J.L.5
Stuhmiller, L.M.6
van Wijk, G.M.7
van den Bosch, H.8
Gardner, M.F.9
Aldern, K.A.10
-
68
-
-
0026662054
-
Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3'-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3'-deoxythymidine
-
Hostetler K.Y., Richman D.D., Carson D.A., Stuhmiller L.M., van Wijk G.M., van den Bosch H. Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3'-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3'-deoxythymidine. Antimicrob. Agents Chemother. 1992, 36:2025-2029.
-
(1992)
Antimicrob. Agents Chemother.
, vol.36
, pp. 2025-2029
-
-
Hostetler, K.Y.1
Richman, D.D.2
Carson, D.A.3
Stuhmiller, L.M.4
van Wijk, G.M.5
van den Bosch, H.6
-
69
-
-
0025262446
-
Synthesis and antiretroviral activity of phospholipid analogs of azidothymidine and other antiviral nucleosides
-
Hostetler K.Y., Stuhmiller L.M., Lenting H.B., van den Bosch H., Richman D.D. Synthesis and antiretroviral activity of phospholipid analogs of azidothymidine and other antiviral nucleosides. J. Biol. Chem. 1990, 265:6112-6117.
-
(1990)
J. Biol. Chem.
, vol.265
, pp. 6112-6117
-
-
Hostetler, K.Y.1
Stuhmiller, L.M.2
Lenting, H.B.3
van den Bosch, H.4
Richman, D.D.5
-
70
-
-
0031919066
-
Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters
-
Jarvis S.M., Thorn J.A., Glue P. Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters. Br. J. Pharmacol. 1998, 123:1587-1592.
-
(1998)
Br. J. Pharmacol.
, vol.123
, pp. 1587-1592
-
-
Jarvis, S.M.1
Thorn, J.A.2
Glue, P.3
-
71
-
-
55249108486
-
Bioreversible protection of nucleoside diphosphates
-
Jessen H.J., Schulz T., Balzarini J., Meier C. Bioreversible protection of nucleoside diphosphates. Angew Chem. Int. Ed. Engl. 2008, 47:8719-8722.
-
(2008)
Angew Chem. Int. Ed. Engl.
, vol.47
, pp. 8719-8722
-
-
Jessen, H.J.1
Schulz, T.2
Balzarini, J.3
Meier, C.4
-
72
-
-
78049256334
-
Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures
-
Jiang Z.G., Cohen J., Marshall L.J., Major E.O. Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures. Antimicrob. Agents Chemother. 2010, 54:4723-4732.
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 4723-4732
-
-
Jiang, Z.G.1
Cohen, J.2
Marshall, L.J.3
Major, E.O.4
-
73
-
-
0025856241
-
Synthesis and anti-HIV activity of some novel phosphorodiamidate derivatives of 3'-azido-3'-deoxythymidine (AZT)
-
Jones B.C.N.M., McGuigan C., O'Conner T.J., Jeffries D.J., Kinchington D. Synthesis and anti-HIV activity of some novel phosphorodiamidate derivatives of 3'-azido-3'-deoxythymidine (AZT). Antiviral. Chem. Chemother. 1991, 2:35-39.
-
(1991)
Antiviral. Chem. Chemother.
, vol.2
, pp. 35-39
-
-
Jones, B.C.N.M.1
McGuigan, C.2
O'Conner, T.J.3
Jeffries, D.J.4
Kinchington, D.5
-
75
-
-
33847689816
-
Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity
-
Ke H., Wang H. Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity. Curr. Top. Med. Chem. 2007, 7:391-403.
-
(2007)
Curr. Top. Med. Chem.
, vol.7
, pp. 391-403
-
-
Ke, H.1
Wang, H.2
-
76
-
-
0038312076
-
Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication
-
Keith K.A., Hitchcock M.J., Lee W.A., Holy A., Kern E.R. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication. Antimicrob. Agents Chemother. 2003, 47:2193-2198.
-
(2003)
Antimicrob. Agents Chemother.
, vol.47
, pp. 2193-2198
-
-
Keith, K.A.1
Hitchcock, M.J.2
Lee, W.A.3
Holy, A.4
Kern, E.R.5
-
77
-
-
0029796135
-
Neighboring group catalysis in the design of nucleotide prodrugs
-
Khamnei S., Torrence P.F. Neighboring group catalysis in the design of nucleotide prodrugs. J. Med. Chem. 1996, 39:4109-4115.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 4109-4115
-
-
Khamnei, S.1
Torrence, P.F.2
-
78
-
-
15444363853
-
Direct measurement of nucleoside monophosphate delivery from a phosphoramidate pronucleotide by stable isotope labeling and LC-ESI(-)-MS/MS
-
Kim J., Chou T.F., Griesgraber G.W., Wagner C.R. Direct measurement of nucleoside monophosphate delivery from a phosphoramidate pronucleotide by stable isotope labeling and LC-ESI(-)-MS/MS. Mol. Pharm. 2004, 1:102-111.
-
(2004)
Mol. Pharm.
, vol.1
, pp. 102-111
-
-
Kim, J.1
Chou, T.F.2
Griesgraber, G.W.3
Wagner, C.R.4
-
79
-
-
77954646871
-
PSI-7851, a pronucleotide of beta-d-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication
-
Lam A.M., Murakami E., Espiritu C., Steuer H.M., Niu C., Keilman M., Bao H., Zennou V., Bourne N., Julander J.G., Morrey J.D., Smee D.F., Frick D.N., Heck J.A., Wang P., Nagarathnam D., Ross B.S., Sofia M.J., Otto M.J., Furman P.A. PSI-7851, a pronucleotide of beta-d-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrob. Agents Chemother. 2010, 54:3187-3196.
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 3187-3196
-
-
Lam, A.M.1
Murakami, E.2
Espiritu, C.3
Steuer, H.M.4
Niu, C.5
Keilman, M.6
Bao, H.7
Zennou, V.8
Bourne, N.9
Julander, J.G.10
Morrey, J.D.11
Smee, D.F.12
Frick, D.N.13
Heck, J.A.14
Wang, P.15
Nagarathnam, D.16
Ross, B.S.17
Sofia, M.J.18
Otto, M.J.19
Furman, P.A.20
more..
-
80
-
-
77953796821
-
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV
-
Lanier E.R., Ptak R.G., Lampert B.M., Keilholz L., Hartman T., Buckheit R.W., Mankowski M.K., Osterling M.C., Almond M.R., Painter G.R. Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV. Antimicrob. Agents Chemother. 2011, 54:2901-2909.
-
(2011)
Antimicrob. Agents Chemother.
, vol.54
, pp. 2901-2909
-
-
Lanier, E.R.1
Ptak, R.G.2
Lampert, B.M.3
Keilholz, L.4
Hartman, T.5
Buckheit, R.W.6
Mankowski, M.K.7
Osterling, M.C.8
Almond, M.R.9
Painter, G.R.10
-
81
-
-
79952136133
-
Development of CMX001 for the Treatment of Poxvirus Infections
-
Lanier R., Trost L., Tippin T., Lampert B., Robertson A., Foster S., Rose M., Painter W., O'Mahony R., Almond M., Painter G. Development of CMX001 for the Treatment of Poxvirus Infections. Viruses 2010, 2:2740-2762.
-
(2010)
Viruses
, vol.2
, pp. 2740-2762
-
-
Lanier, R.1
Trost, L.2
Tippin, T.3
Lampert, B.4
Robertson, A.5
Foster, S.6
Rose, M.7
Painter, W.8
O'Mahony, R.9
Almond, M.10
Painter, G.11
-
82
-
-
18244398917
-
Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue
-
Lee W.A., He G.X., Eisenberg E., Cihlar T., Swaminathan S., Mulato A., Cundy K.C. Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue. Antimicrob. Agents Chemother. 2005, 49:1898-1906.
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 1898-1906
-
-
Lee, W.A.1
He, G.X.2
Eisenberg, E.3
Cihlar, T.4
Swaminathan, S.5
Mulato, A.6
Cundy, K.C.7
-
83
-
-
33747125380
-
Perspectives on the development of acyclic nucleotide analogs as antiviral drugs
-
Lee W.A., Martin J.C. Perspectives on the development of acyclic nucleotide analogs as antiviral drugs. Antiviral Res. 2006, 71:254-259.
-
(2006)
Antiviral Res.
, vol.71
, pp. 254-259
-
-
Lee, W.A.1
Martin, J.C.2
-
84
-
-
33745031316
-
Enzymes involved in the bioconversion of ester-based prodrugs
-
Liederer B.M., Borchardt R.T. Enzymes involved in the bioconversion of ester-based prodrugs. J. Pharm. Sci. 2006, 95:1177-1195.
-
(2006)
J. Pharm. Sci.
, vol.95
, pp. 1177-1195
-
-
Liederer, B.M.1
Borchardt, R.T.2
-
85
-
-
0015466351
-
Synthesis and antitumor and antiviral activities of 1-β-d-arabinofuranosylpyrimidine 3',5'-cyclic phosphates
-
Long R.A., Szekeres G.L., Khwaja T.A., Sidwell R.W., Simon L.N., Robins R.K. Synthesis and antitumor and antiviral activities of 1-β-d-arabinofuranosylpyrimidine 3',5'-cyclic phosphates. J. Med. Chem. 1972, 15:1215-1218.
-
(1972)
J. Med. Chem.
, vol.15
, pp. 1215-1218
-
-
Long, R.A.1
Szekeres, G.L.2
Khwaja, T.A.3
Sidwell, R.W.4
Simon, L.N.5
Robins, R.K.6
-
86
-
-
77953325671
-
Discovery of GS-9131: design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148
-
Mackman R.L., Ray A.S., Hui H.C., Zhang L., Birkus G., Boojamra C.G., Desai M.C., Douglas J.L., Gao Y., Grant D., Laflamme G., Lin K.Y., Markevitch D.Y., Mishra R., McDermott M., Pakdaman R., Petrakovsky O.V., Vela J.E., Cihlar T. Discovery of GS-9131: design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148. Bioorg. Med. Chem. 2010, 18:3606-3617.
-
(2010)
Bioorg. Med. Chem.
, vol.18
, pp. 3606-3617
-
-
Mackman, R.L.1
Ray, A.S.2
Hui, H.C.3
Zhang, L.4
Birkus, G.5
Boojamra, C.G.6
Desai, M.C.7
Douglas, J.L.8
Gao, Y.9
Grant, D.10
Laflamme, G.11
Lin, K.Y.12
Markevitch, D.Y.13
Mishra, R.14
McDermott, M.15
Pakdaman, R.16
Petrakovsky, O.V.17
Vela, J.E.18
Cihlar, T.19
-
87
-
-
80054857205
-
-
GS-7340 demonstrates greater declines in HIV-1 RNA than TDF during 14 days of monotherapy in HIV-1-infected subjects, In: 18th Conference on Retroviruses and Opportunistic Infections, Abstract 152LB, Boston, MA, USA.
-
Markowitz, M., Zolopa, A., Ruane, P., Squires, K., Zhong, L., Kearney, B.P., Lee, W., 2011. GS-7340 demonstrates greater declines in HIV-1 RNA than TDF during 14 days of monotherapy in HIV-1-infected subjects, In: 18th Conference on Retroviruses and Opportunistic Infections, Abstract 152LB, Boston, MA, USA.
-
(2011)
-
-
Markowitz, M.1
Zolopa, A.2
Ruane, P.3
Squires, K.4
Zhong, L.5
Kearney, B.P.6
Lee, W.7
-
88
-
-
73549122138
-
Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: a brief history of stavudine (D4T) and its comparison with other dideoxynucleosides
-
Martin J.C., Hitchcock M.J., De Clercq E., Prusoff W.H. Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: a brief history of stavudine (D4T) and its comparison with other dideoxynucleosides. Antiviral Res. 2010, 85:34-38.
-
(2010)
Antiviral Res.
, vol.85
, pp. 34-38
-
-
Martin, J.C.1
Hitchcock, M.J.2
De Clercq, E.3
Prusoff, W.H.4
-
89
-
-
0028060330
-
Certain phosphoramidate derivatives of dideoxy uridine (ddU) are active against HIV and successfully by-pass thymidine kinase
-
McGuigan C., Bellevergue P., Sheeka H., Mahmood N., Hay A.J. Certain phosphoramidate derivatives of dideoxy uridine (ddU) are active against HIV and successfully by-pass thymidine kinase. FEBS Lett. 1994, 351:11-14.
-
(1994)
FEBS Lett.
, vol.351
, pp. 11-14
-
-
McGuigan, C.1
Bellevergue, P.2
Sheeka, H.3
Mahmood, N.4
Hay, A.J.5
-
90
-
-
0029975897
-
Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite
-
McGuigan C., Cahard D., Sheeka H.M., De Clercq E., Balzarini J. Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. J. Med. Chem. 1996, 39:1748-1753.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 1748-1753
-
-
McGuigan, C.1
Cahard, D.2
Sheeka, H.M.3
De Clercq, E.4
Balzarini, J.5
-
91
-
-
0025801734
-
Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3'-azido-3'-deoxythymidine (AZT): potent activity of the trichloroethyl methoxyalaninyl compound
-
McGuigan C., Devine K.G., O'Connor T.J., Kinchington D. Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3'-azido-3'-deoxythymidine (AZT): potent activity of the trichloroethyl methoxyalaninyl compound. Antiviral Res. 1991, 15:255-263.
-
(1991)
Antiviral Res.
, vol.15
, pp. 255-263
-
-
McGuigan, C.1
Devine, K.G.2
O'Connor, T.J.3
Kinchington, D.4
-
92
-
-
0026341853
-
Attempts to introduce chemotherapeutic nucleotides into cells: studies on the anti-HIV agent FDT
-
McGuigan C., Jones B.C.N.M., Devine K.G., Nicholls S.R., O'Conner T.J., Kinchington D. Attempts to introduce chemotherapeutic nucleotides into cells: studies on the anti-HIV agent FDT. Biorganic. Med. Chem. Lett. 1991, 1:729-732.
-
(1991)
Biorganic. Med. Chem. Lett.
, vol.1
, pp. 729-732
-
-
McGuigan, C.1
Jones, B.C.N.M.2
Devine, K.G.3
Nicholls, S.R.4
O'Conner, T.J.5
Kinchington, D.6
-
93
-
-
77955426384
-
Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus
-
McGuigan C., Madela K., Aljarah M., Gilles A., Brancale A., Zonta N., Chamberlain S., Vernachio J., Hutchins J., Hall A., Ames B., Gorovits E., Ganguly B., Kolykhalov A., Wang J., Muhammad J., Patti J.M., Henson G. Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus. Bioorg. Med. Chem. Lett. 2010, 20:4850-4854.
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 4850-4854
-
-
McGuigan, C.1
Madela, K.2
Aljarah, M.3
Gilles, A.4
Brancale, A.5
Zonta, N.6
Chamberlain, S.7
Vernachio, J.8
Hutchins, J.9
Hall, A.10
Ames, B.11
Gorovits, E.12
Ganguly, B.13
Kolykhalov, A.14
Wang, J.15
Muhammad, J.16
Patti, J.M.17
Henson, G.18
-
94
-
-
67649999890
-
The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus
-
McGuigan C., Perrone P., Madela K., Neyts J. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus. Bioorg. Med. Chem. Lett. 2009, 19:4316-4320.
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 4316-4320
-
-
McGuigan, C.1
Perrone, P.2
Madela, K.3
Neyts, J.4
-
95
-
-
0024337542
-
Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug AraA
-
McGuigan C., Tollerfield S.M., Riley P.A. Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug AraA. Nucleic Acids Res. 1989, 17:6065-6075.
-
(1989)
Nucleic Acids Res.
, vol.17
, pp. 6065-6075
-
-
McGuigan, C.1
Tollerfield, S.M.2
Riley, P.A.3
-
96
-
-
73449119606
-
Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells
-
Mehellou Y., Balzarini J., McGuigan C. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells. ChemMedChem 2009, 4:1779-1791.
-
(2009)
ChemMedChem
, vol.4
, pp. 1779-1791
-
-
Mehellou, Y.1
Balzarini, J.2
McGuigan, C.3
-
97
-
-
33747093326
-
Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules
-
Meier C., Balzarini J. Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules. Antiviral Res. 2006, 71:282-292.
-
(2006)
Antiviral Res.
, vol.71
, pp. 282-292
-
-
Meier, C.1
Balzarini, J.2
-
98
-
-
29144464769
-
CycloSal-PMEA and cycloAmb-PMEA: potentially new phosphonate prodrugs based on the cycloSal-pronucleotide approach
-
Meier C., Gorbig U., Muller C., Balzarini J. CycloSal-PMEA and cycloAmb-PMEA: potentially new phosphonate prodrugs based on the cycloSal-pronucleotide approach. J. Med. Chem. 2005, 48:8079-8086.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 8079-8086
-
-
Meier, C.1
Gorbig, U.2
Muller, C.3
Balzarini, J.4
-
100
-
-
0032560234
-
CycloSal-2',3'-dideoxy-2',3'-didehydrothymidine monophosphate (cycloSal-d4TMP): synthesis and antiviral evaluation of a new d4TMP delivery system
-
Meier C., Lorey M., De Clercq E., Balzarini J. CycloSal-2',3'-dideoxy-2',3'-didehydrothymidine monophosphate (cycloSal-d4TMP): synthesis and antiviral evaluation of a new d4TMP delivery system. J. Med. Chem. 1998, 41:1417-1427.
-
(1998)
J. Med. Chem.
, vol.41
, pp. 1417-1427
-
-
Meier, C.1
Lorey, M.2
De Clercq, E.3
Balzarini, J.4
-
101
-
-
0031038255
-
Conversion of 1-[((S)-2-hydroxy-2-oxo-1, 4, 2-dioxaphosphorinan-5-yl)methyl]cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase
-
Mendel D.B., Cihlar T., Moon K., Chen M.S. Conversion of 1-[((S)-2-hydroxy-2-oxo-1, 4, 2-dioxaphosphorinan-5-yl)methyl]cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase. Antimicrob. Agents Chemother. 1997, 41:641-646.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 641-646
-
-
Mendel, D.B.1
Cihlar, T.2
Moon, K.3
Chen, M.S.4
-
102
-
-
67650409704
-
Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine
-
Meppen M., Pacini B., Bazzo R., Koch U., Leone J.F., Koeplinger K.A., Rowley M., Altamura S., Di Marco A., Fiore F., Giuliano C., Gonzalez-Paz O., Laufer R., Pucci V., Narjes F., Gardelli C. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine. Eur. J. Med. Chem. 2009, 44:3765-3770.
-
(2009)
Eur. J. Med. Chem.
, vol.44
, pp. 3765-3770
-
-
Meppen, M.1
Pacini, B.2
Bazzo, R.3
Koch, U.4
Leone, J.F.5
Koeplinger, K.A.6
Rowley, M.7
Altamura, S.8
Di Marco, A.9
Fiore, F.10
Giuliano, C.11
Gonzalez-Paz, O.12
Laufer, R.13
Pucci, V.14
Narjes, F.15
Gardelli, C.16
-
103
-
-
0025605531
-
Targeting of antiviral drugs to T4-lymphocytes. Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro
-
Molema G., Jansen R.W., Pauwels R., de Clercq E., Meijer D.K. Targeting of antiviral drugs to T4-lymphocytes. Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro. Biochem. Pharmacol. 1990, 40:2603-2610.
-
(1990)
Biochem. Pharmacol.
, vol.40
, pp. 2603-2610
-
-
Molema, G.1
Jansen, R.W.2
Pauwels, R.3
de Clercq, E.4
Meijer, D.K.5
-
104
-
-
67649966294
-
Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo
-
Morrey J.D., Korba B.E., Beadle J.R., Wyles D.L., Hostetler K.Y. Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo. Antimicrob. Agents Chemother. 2009, 53:2865-2870.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 2865-2870
-
-
Morrey, J.D.1
Korba, B.E.2
Beadle, J.R.3
Wyles, D.L.4
Hostetler, K.Y.5
-
105
-
-
78049375232
-
Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977
-
Murakami E., Tolstykh T., Bao H., Niu C., Steuer H.M., Bao D., Chang W., Espiritu C., Bansal S., Lam A.M., Otto M.J., Sofia M.J., Furman P.A. Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977. J. Biol. Chem. 2010, 285:34337-34347.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 34337-34347
-
-
Murakami, E.1
Tolstykh, T.2
Bao, H.3
Niu, C.4
Steuer, H.M.5
Bao, D.6
Chang, W.7
Espiritu, C.8
Bansal, S.9
Lam, A.M.10
Otto, M.J.11
Sofia, M.J.12
Furman, P.A.13
-
106
-
-
34948857943
-
Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections
-
Painter G.R., Almond M.R., Trost L.C., Lampert B.M., Neyts J., De Clercq E., Korba B.E., Aldern K.A., Beadle J.R., Hostetler K.Y. Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections. Antimicrob. Agents Chemother. 2007, 51:3505-3509.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 3505-3509
-
-
Painter, G.R.1
Almond, M.R.2
Trost, L.C.3
Lampert, B.M.4
Neyts, J.5
De Clercq, E.6
Korba, B.E.7
Aldern, K.A.8
Beadle, J.R.9
Hostetler, K.Y.10
-
107
-
-
78951485140
-
Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001
-
Paolino K., Sande J., Perez E., Loechelt B., Jantausch B., Painter W., Anderson M., Tippin T., Lanier E.R., Fry T., DeBiasi R.L. Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001. J. Clin. Virol. 2011, 50:167-170.
-
(2011)
J. Clin. Virol.
, vol.50
, pp. 167-170
-
-
Paolino, K.1
Sande, J.2
Perez, E.3
Loechelt, B.4
Jantausch, B.5
Painter, W.6
Anderson, M.7
Tippin, T.8
Lanier, E.R.9
Fry, T.10
DeBiasi, R.L.11
-
108
-
-
0027722026
-
Rational design for cytosolic delivery of nucleoside monophopshates: " SATE" and " DTE" as enzyme-liabile transient phosphate protecting groups
-
Perigaud C., Gosselin G., Lefebvre I., Giradet J.L., Benzaria S., Barber I., Imbach J.L. Rational design for cytosolic delivery of nucleoside monophopshates: " SATE" and " DTE" as enzyme-liabile transient phosphate protecting groups. Bioorg. Med. Chem. Lett. 1993, 3:2521-2526.
-
(1993)
Bioorg. Med. Chem. Lett.
, vol.3
, pp. 2521-2526
-
-
Perigaud, C.1
Gosselin, G.2
Lefebvre, I.3
Giradet, J.L.4
Benzaria, S.5
Barber, I.6
Imbach, J.L.7
-
109
-
-
35848930168
-
First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus
-
Perrone P., Daverio F., Valente R., Rajyaguru S., Martin J.A., Leveque V., Le Pogam S., Najera I., Klumpp K., Smith D.B., McGuigan C. First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus. J. Med. Chem. 2007, 50:5463-5470.
-
(2007)
J. Med. Chem.
, vol.50
, pp. 5463-5470
-
-
Perrone, P.1
Daverio, F.2
Valente, R.3
Rajyaguru, S.4
Martin, J.A.5
Leveque, V.6
Le Pogam, S.7
Najera, I.8
Klumpp, K.9
Smith, D.B.10
McGuigan, C.11
-
110
-
-
34247259962
-
Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside
-
Perrone P., Luoni G.M., Kelleher M.R., Daverio F., Angell A., Mulready S., Congiatu C., Rajyaguru S., Martin J.A., Leveque V., Le Pogam S., Najera I., Klumpp K., Smith D.B., McGuigan C. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside. J. Med. Chem. 2007, 50:1840-1849.
-
(2007)
J. Med. Chem.
, vol.50
, pp. 1840-1849
-
-
Perrone, P.1
Luoni, G.M.2
Kelleher, M.R.3
Daverio, F.4
Angell, A.5
Mulready, S.6
Congiatu, C.7
Rajyaguru, S.8
Martin, J.A.9
Leveque, V.10
Le Pogam, S.11
Najera, I.12
Klumpp, K.13
Smith, D.B.14
McGuigan, C.15
-
111
-
-
0025895220
-
Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity
-
Piantadosi C., Marasco C.J., Morris-Natschke S.L., Meyer K.L., Gumus F., Surles J.R., Ishaq K.S., Kucera L.S., Iyer N., Wallen C.A., et al. Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity. J. Med. Chem. 1991, 34:1408-1414.
-
(1991)
J. Med. Chem.
, vol.34
, pp. 1408-1414
-
-
Piantadosi, C.1
Marasco, C.J.2
Morris-Natschke, S.L.3
Meyer, K.L.4
Gumus, F.5
Surles, J.R.6
Ishaq, K.S.7
Kucera, L.S.8
Iyer, N.9
Wallen, C.A.10
-
112
-
-
0017117688
-
Studies on nucleotide diphosphate diacylglycerol specificity of acidic phospholipid biosynthesis in rat liver subcellular fractions
-
Poorthuis B.J., Hostetler K.Y. Studies on nucleotide diphosphate diacylglycerol specificity of acidic phospholipid biosynthesis in rat liver subcellular fractions. Biochim. Biophys. Acta 1976, 431:408-415.
-
(1976)
Biochim. Biophys. Acta
, vol.431
, pp. 408-415
-
-
Poorthuis, B.J.1
Hostetler, K.Y.2
-
113
-
-
0000001006
-
Derivatives of cyclic 3',5'-adenosine monophosphate
-
Posternak T., Sutherland E.W., Henion W.F. Derivatives of cyclic 3',5'-adenosine monophosphate. Biochim. Biophys. Acta 1962, 65:558-560.
-
(1962)
Biochim. Biophys. Acta
, vol.65
, pp. 558-560
-
-
Posternak, T.1
Sutherland, E.W.2
Henion, W.F.3
-
114
-
-
0022461410
-
Synthesis and antiherpes virus activity of phosphate and phosphonate derivatives of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine
-
Prisbe E.J., Martin J.C., McGee D.P., Barker M.F., Smee D.F., Duke A.E., Matthews T.R., Verheyden J.P. Synthesis and antiherpes virus activity of phosphate and phosphonate derivatives of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine. J. Med. Chem. 1986, 29:671-675.
-
(1986)
J. Med. Chem.
, vol.29
, pp. 671-675
-
-
Prisbe, E.J.1
Martin, J.C.2
McGee, D.P.3
Barker, M.F.4
Smee, D.F.5
Duke, A.E.6
Matthews, T.R.7
Verheyden, J.P.8
-
115
-
-
0027433373
-
Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process
-
Puech F., Gosselin G., Lefebvre I., Pompon A., Aubertin A.M., Kirn A., Imbach J.L. Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process. Antiviral Res. 1993, 22:155-174.
-
(1993)
Antiviral Res.
, vol.22
, pp. 155-174
-
-
Puech, F.1
Gosselin, G.2
Lefebvre, I.3
Pompon, A.4
Aubertin, A.M.5
Kirn, A.6
Imbach, J.L.7
-
117
-
-
38649131311
-
Intracellular metabolism of the nucleotide prodrug GS-9131, a potent anti-human immunodeficiency virus agent
-
Ray A.S., Vela J.E., Boojamra C.G., Zhang L., Hui H., Callebaut C., Stray K., Lin K.Y., Gao Y., Mackman R.L., Cihlar T. Intracellular metabolism of the nucleotide prodrug GS-9131, a potent anti-human immunodeficiency virus agent. Antimicrob. Agents Chemother. 2008, 52:648-654.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 648-654
-
-
Ray, A.S.1
Vela, J.E.2
Boojamra, C.G.3
Zhang, L.4
Hui, H.5
Callebaut, C.6
Stray, K.7
Lin, K.Y.8
Gao, Y.9
Mackman, R.L.10
Cihlar, T.11
-
118
-
-
78449306203
-
2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938
-
Reddy P.G., Bao D., Chang W., Chun B.K., Du J., Nagarathnam D., Rachakonda S., Ross B.S., Zhang H.R., Bansal S., Espiritu C.L., Keilman M., Lam A.M., Niu C., Steuer H.M., Furman P.A., Otto M.J., Sofia M.J. 2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938. Bioorg. Med. Chem. Lett. 2010, 20:7376-7380.
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 7376-7380
-
-
Reddy, P.G.1
Bao, D.2
Chang, W.3
Chun, B.K.4
Du, J.5
Nagarathnam, D.6
Rachakonda, S.7
Ross, B.S.8
Zhang, H.R.9
Bansal, S.10
Espiritu, C.L.11
Keilman, M.12
Lam, A.M.13
Niu, C.14
Steuer, H.M.15
Furman, P.A.16
Otto, M.J.17
Sofia, M.J.18
-
119
-
-
0021742976
-
Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides
-
Revankar G.R., Gupta P.K., Adams A.D., Dalley N.K., McKernan P.A., Cook P.D., Canonico P.G., Robins R.K. Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides. J. Med. Chem. 1984, 27:1389-1396.
-
(1984)
J. Med. Chem.
, vol.27
, pp. 1389-1396
-
-
Revankar, G.R.1
Gupta, P.K.2
Adams, A.D.3
Dalley, N.K.4
McKernan, P.A.5
Cook, P.D.6
Canonico, P.G.7
Robins, R.K.8
-
120
-
-
0031916651
-
Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl)PMPA
-
Robbins B.L., Srinivas R.V., Kim C., Bischofberger N., Fridland A. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl)PMPA. Antimicrob. Agents Chemother. 1998, 42:612-617.
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 612-617
-
-
Robbins, B.L.1
Srinivas, R.V.2
Kim, C.3
Bischofberger, N.4
Fridland, A.5
-
121
-
-
0029155592
-
Synthesis, bioactivation and anti-HIV activity of 4-acyloxybenzyl bis(Nucleosid-5'-yl) phosphates
-
Routledge A., Walker I., Freeman S., Hay A., Mahmood N. Synthesis, bioactivation and anti-HIV activity of 4-acyloxybenzyl bis(Nucleosid-5'-yl) phosphates. Nucleosides Nucleotides Nucleic Acids 1995, 14:1545-1558.
-
(1995)
Nucleosides Nucleotides Nucleic Acids
, vol.14
, pp. 1545-1558
-
-
Routledge, A.1
Walker, I.2
Freeman, S.3
Hay, A.4
Mahmood, N.5
-
122
-
-
0032834955
-
Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine
-
Saboulard D., Naesens L., Cahard D., Salgado A., Pathirana R., Velazquez S., McGuigan C., De Clercq E., Balzarini J. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine. Mol. Pharmacol. 1999, 56:693-704.
-
(1999)
Mol. Pharmacol.
, vol.56
, pp. 693-704
-
-
Saboulard, D.1
Naesens, L.2
Cahard, D.3
Salgado, A.4
Pathirana, R.5
Velazquez, S.6
McGuigan, C.7
De Clercq, E.8
Balzarini, J.9
-
123
-
-
0026524003
-
Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection
-
Sastry J.K., Nehete P.N., Khan S., Nowak B.J., Plunkett W., Arlinghaus R.B., Farquhar D. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection. Mol. Pharmacol. 1992, 41:441-445.
-
(1992)
Mol. Pharmacol.
, vol.41
, pp. 441-445
-
-
Sastry, J.K.1
Nehete, P.N.2
Khan, S.3
Nowak, B.J.4
Plunkett, W.5
Arlinghaus, R.B.6
Farquhar, D.7
-
124
-
-
0017811137
-
9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group
-
Schaeffer H.J., Beauchamp L., de Miranda P., Elion G.B., Bauer D.J., Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature 1978, 272:583-585.
-
(1978)
Nature
, vol.272
, pp. 583-585
-
-
Schaeffer, H.J.1
Beauchamp, L.2
de Miranda, P.3
Elion, G.B.4
Bauer, D.J.5
Collins, P.6
-
125
-
-
0008099016
-
Rational design of a new series of mixed anti-HIV pronucleotides
-
Schlienger N., Beltran T., Perigaud C., Lefebvre I., Pompon A., Aubertin A.M., Gosselin G., Imbach J.L. Rational design of a new series of mixed anti-HIV pronucleotides. Bioorg. Med. Chem. Lett. 1998, 8:3003-3006.
-
(1998)
Bioorg. Med. Chem. Lett.
, vol.8
, pp. 3003-3006
-
-
Schlienger, N.1
Beltran, T.2
Perigaud, C.3
Lefebvre, I.4
Pompon, A.5
Aubertin, A.M.6
Gosselin, G.7
Imbach, J.L.8
-
126
-
-
0034676311
-
S-Acyl-2-thioethyl aryl phosphotriester derivatives as mononucleotide prodrugs
-
Schlienger N., Peyrottes S., Kassem T., Imbach J.L., Gosselin G., Aubertin A.M., Perigaud C. S-Acyl-2-thioethyl aryl phosphotriester derivatives as mononucleotide prodrugs. J. Med. Chem. 2000, 43:4570-4574.
-
(2000)
J. Med. Chem.
, vol.43
, pp. 4570-4574
-
-
Schlienger, N.1
Peyrottes, S.2
Kassem, T.3
Imbach, J.L.4
Gosselin, G.5
Aubertin, A.M.6
Perigaud, C.7
-
127
-
-
0037333460
-
Prodrugs of biologically active phosphate esters
-
Schultz C. Prodrugs of biologically active phosphate esters. Bioorg. Med. Chem. 2003, 11:885-898.
-
(2003)
Bioorg. Med. Chem.
, vol.11
, pp. 885-898
-
-
Schultz, C.1
-
128
-
-
0030997246
-
Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats
-
Shaw J.P., Louie M.S., Krishnamurthy V.V., Arimilli M.N., Jones R.J., Bidgood A.M., Lee W.A., Cundy K.C. Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats. Drug Metab. Dispos. 1997, 25:362-366.
-
(1997)
Drug Metab. Dispos.
, vol.25
, pp. 362-366
-
-
Shaw, J.P.1
Louie, M.S.2
Krishnamurthy, V.V.3
Arimilli, M.N.4
Jones, R.J.5
Bidgood, A.M.6
Lee, W.A.7
Cundy, K.C.8
-
129
-
-
0031430945
-
Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs
-
Shaw J.P., Sueoko C.M., Oliyai R., Lee W.A., Arimilli M.N., Kim C.U., Cundy K.C. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs. Pharm. Res. 1997, 14:1824-1829.
-
(1997)
Pharm. Res.
, vol.14
, pp. 1824-1829
-
-
Shaw, J.P.1
Sueoko, C.M.2
Oliyai, R.3
Lee, W.A.4
Arimilli, M.N.5
Kim, C.U.6
Cundy, K.C.7
-
130
-
-
77957913871
-
Discovery of a beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus
-
Sofia M.J., Bao D., Chang W., Du J., Nagarathnam D., Rachakonda S., Reddy P.G., Ross B.S., Wang P., Zhang H.R., Bansal S., Espiritu C., Keilman M., Lam A.M., Steuer H.M., Niu C., Otto M.J., Furman P.A. Discovery of a beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. J. Med. Chem. 2010, 53:7202-7218.
-
(2010)
J. Med. Chem.
, vol.53
, pp. 7202-7218
-
-
Sofia, M.J.1
Bao, D.2
Chang, W.3
Du, J.4
Nagarathnam, D.5
Rachakonda, S.6
Reddy, P.G.7
Ross, B.S.8
Wang, P.9
Zhang, H.R.10
Bansal, S.11
Espiritu, C.12
Keilman, M.13
Lam, A.M.14
Steuer, H.M.15
Niu, C.16
Otto, M.J.17
Furman, P.A.18
-
131
-
-
0027440278
-
Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates
-
Srinivas R.V., Robbins B.L., Connelly M.C., Gong Y.F., Bischofberger N., Fridland A. Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates. Antimicrob. Agents Chemother. 1993, 37:2247-2250.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 2247-2250
-
-
Srinivas, R.V.1
Robbins, B.L.2
Connelly, M.C.3
Gong, Y.F.4
Bischofberger, N.5
Fridland, A.6
-
132
-
-
0026739035
-
Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine
-
Starrett J.E., Tortolani D.R., Hitchcock M.J., Martin J.C., Mansuri M.M. Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine. Antiviral Res. 1992, 19:267-273.
-
(1992)
Antiviral Res.
, vol.19
, pp. 267-273
-
-
Starrett, J.E.1
Tortolani, D.R.2
Hitchcock, M.J.3
Martin, J.C.4
Mansuri, M.M.5
-
133
-
-
0019276096
-
Prodrugs and site-specific drug delivery
-
Stella V.J., Himmelstein K.J. Prodrugs and site-specific drug delivery. J. Med. Chem. 1980, 23:1275-1282.
-
(1980)
J. Med. Chem.
, vol.23
, pp. 1275-1282
-
-
Stella, V.J.1
Himmelstein, K.J.2
-
134
-
-
0032823876
-
Development and optimization of anti-HIV nucleoside analogs and prodrugs: a review of their cellular pharmacology, structure-activity relationships and pharmacokinetics
-
Tan X., Chu C.K., Boudinot F.D. Development and optimization of anti-HIV nucleoside analogs and prodrugs: a review of their cellular pharmacology, structure-activity relationships and pharmacokinetics. Adv. Drug Deliv. Rev. 1999, 39:117-151.
-
(1999)
Adv. Drug Deliv. Rev.
, vol.39
, pp. 117-151
-
-
Tan, X.1
Chu, C.K.2
Boudinot, F.D.3
-
135
-
-
0029761595
-
Synthesis and antiretroviral evaluation of new alkoxy and aryloxy phosphate derivatives of 3'-azido-3'-deoxythymidine
-
Tsotinis A., Calogeropoulou T., Koufaki M., Souli C., Balzarini J., De Clercq E., Makriyannis A. Synthesis and antiretroviral evaluation of new alkoxy and aryloxy phosphate derivatives of 3'-azido-3'-deoxythymidine. J. Med. Chem. 1996, 39:3418-3422.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 3418-3422
-
-
Tsotinis, A.1
Calogeropoulou, T.2
Koufaki, M.3
Souli, C.4
Balzarini, J.5
De Clercq, E.6
Makriyannis, A.7
-
136
-
-
79960559670
-
Synthesis and antiviral evaluation of 9-(S)-[3-Alkoxy-2-(phosphonomethoxy)propyl] nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication
-
Valiaeva N., Wyles D.L., Schooley R.T., Hwu J.B., Beadle J.R., Prichard M.N., Hostetler K.Y. Synthesis and antiviral evaluation of 9-(S)-[3-Alkoxy-2-(phosphonomethoxy)propyl] nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication. Bioorg. Med. Chem. 2011, 19:4616-4625.
-
(2011)
Bioorg. Med. Chem.
, vol.19
, pp. 4616-4625
-
-
Valiaeva, N.1
Wyles, D.L.2
Schooley, R.T.3
Hwu, J.B.4
Beadle, J.R.5
Prichard, M.N.6
Hostetler, K.Y.7
-
137
-
-
0033796942
-
Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases
-
Van Rompay A.R., Johansson M., Karlsson A. Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol. Ther. 2000, 87:189-198.
-
(2000)
Pharmacol. Ther.
, vol.87
, pp. 189-198
-
-
Van Rompay, A.R.1
Johansson, M.2
Karlsson, A.3
-
138
-
-
0028220406
-
Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT
-
van Wijk G.M., Hostetler K.Y., Kroneman E., Richman D.D., Sridhar C.N., Kumar R., van den Bosch H. Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT. Chem. Phys. Lipids 1994, 70:213-222.
-
(1994)
Chem. Phys. Lipids
, vol.70
, pp. 213-222
-
-
van Wijk, G.M.1
Hostetler, K.Y.2
Kroneman, E.3
Richman, D.D.4
Sridhar, C.N.5
Kumar, R.6
van den Bosch, H.7
-
139
-
-
67649997342
-
Mitochondrial DNA depletion in rat liver induced by fosalvudine tidoxil, a novel nucleoside reverse transcriptase inhibitor prodrug
-
Venhoff A.C., Lebrecht D., Reuss F.U., Heckl-Ostreicher B., Wehr R., Walker U.A., Venhoff N. Mitochondrial DNA depletion in rat liver induced by fosalvudine tidoxil, a novel nucleoside reverse transcriptase inhibitor prodrug. Antimicrob. Agents Chemother. 2009, 53:2748-2751.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 2748-2751
-
-
Venhoff, A.C.1
Lebrecht, D.2
Reuss, F.U.3
Heckl-Ostreicher, B.4
Wehr, R.5
Walker, U.A.6
Venhoff, N.7
-
140
-
-
26644432738
-
" Lock-in" modified cyclosal nucleotides - the second generation of cyclosal prodrugs
-
Vukadinovic D., Boge N.P., Balzarini J., Meier C. " Lock-in" modified cyclosal nucleotides - the second generation of cyclosal prodrugs. Nucleosides, Nucleotides Nucleic Acids 2005, 24:939-942.
-
(2005)
Nucleosides, Nucleotides Nucleic Acids
, vol.24
, pp. 939-942
-
-
Vukadinovic, D.1
Boge, N.P.2
Balzarini, J.3
Meier, C.4
-
141
-
-
0029118114
-
Aromatic amino acid phosphoramidate di- and triesters of 3'-azido-3'-deoxythymidine (AZT) are non-toxic inhibitors of HIV-1 replication
-
Wagner C.R., McIntee E.J., Schinazi R.F., Abraham T.W. Aromatic amino acid phosphoramidate di- and triesters of 3'-azido-3'-deoxythymidine (AZT) are non-toxic inhibitors of HIV-1 replication. Bioorg. Med. Chem. Lett. 1995, 5:1809-1824.
-
(1995)
Bioorg. Med. Chem. Lett.
, vol.5
, pp. 1809-1824
-
-
Wagner, C.R.1
McIntee, E.J.2
Schinazi, R.F.3
Abraham, T.W.4
-
142
-
-
19944428854
-
Synthesis of AZT 5'-triphosphate mimics and their inhibitory effects on HIV-1 reverse transcriptase
-
Wang G., Boyle N., Chen F., Rajappan V., Fagan P., Brooks J.L., Hurd T., Leeds J.M., Rajwanshi V.K., Jin Y., Prhavc M., Bruice T.W., Cook P.D. Synthesis of AZT 5'-triphosphate mimics and their inhibitory effects on HIV-1 reverse transcriptase. J. Med. Chem. 2004, 47:6902-6913.
-
(2004)
J. Med. Chem.
, vol.47
, pp. 6902-6913
-
-
Wang, G.1
Boyle, N.2
Chen, F.3
Rajappan, V.4
Fagan, P.5
Brooks, J.L.6
Hurd, T.7
Leeds, J.M.8
Rajwanshi, V.K.9
Jin, Y.10
Prhavc, M.11
Bruice, T.W.12
Cook, P.D.13
-
143
-
-
77952303898
-
Understanding specificity in metabolic pathways - structural biology of human nucleotide metabolism
-
Welin M., Nordlund P. Understanding specificity in metabolic pathways - structural biology of human nucleotide metabolism. Biochem. Biophys. Res. Commun. 2010, 396:157-163.
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.396
, pp. 157-163
-
-
Welin, M.1
Nordlund, P.2
-
144
-
-
0034956253
-
Mitochondrial toxicity and HIV therapy
-
White A.J. Mitochondrial toxicity and HIV therapy. Sex Transm. Infect. 2001, 77:158-173.
-
(2001)
Sex Transm. Infect.
, vol.77
, pp. 158-173
-
-
White, A.J.1
-
145
-
-
67650003697
-
GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions
-
Wolfgang G.H., Shibata R., Wang J., Ray A.S., Wu S., Doerrfler E., Reiser H., Lee W.A., Birkus G., Christensen N.D., Andrei G., Snoeck R. GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions. Antimicrob. Agents Chemother. 2009, 53:2777-2784.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 2777-2784
-
-
Wolfgang, G.H.1
Shibata, R.2
Wang, J.3
Ray, A.S.4
Wu, S.5
Doerrfler, E.6
Reiser, H.7
Lee, W.A.8
Birkus, G.9
Christensen, N.D.10
Andrei, G.11
Snoeck, R.12
-
146
-
-
80054846702
-
-
Enhanced cellular penetration of ODE-(S)-MPMPA accounts for its prolonged post-exposure anti-HCV activity, In: 24th International Conference on Antiviral Research, Sofia, Bulgaria.
-
Wyles, D.L., Jones, K.A., Valiaeva, N., Beadle, J.R., Schooley, R.T., Hostetler, K.Y., 2011. Enhanced cellular penetration of ODE-(S)-MPMPA accounts for its prolonged post-exposure anti-HCV activity, In: 24th International Conference on Antiviral Research, Sofia, Bulgaria.
-
(2011)
-
-
Wyles, D.L.1
Jones, K.A.2
Valiaeva, N.3
Beadle, J.R.4
Schooley, R.T.5
Hostetler, K.Y.6
-
147
-
-
67049086876
-
The octadecyloxyethyl ester of (S)-9-[3-hydroxy-2-(phosphonomethoxy) propyl]adenine is a potent and selective inhibitor of hepatitis C virus replication in genotype 1A, 1B, and 2A replicons
-
Wyles D.L., Kaihara K.A., Korba B.E., Schooley R.T., Beadle J.R., Hostetler K.Y. The octadecyloxyethyl ester of (S)-9-[3-hydroxy-2-(phosphonomethoxy) propyl]adenine is a potent and selective inhibitor of hepatitis C virus replication in genotype 1A, 1B, and 2A replicons. Antimicrob. Agents Chemother. 2009, 53:2660-2662.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 2660-2662
-
-
Wyles, D.L.1
Kaihara, K.A.2
Korba, B.E.3
Schooley, R.T.4
Beadle, J.R.5
Hostetler, K.Y.6
-
148
-
-
12144255999
-
Nucleotides and pronucleotides of 2,2-bis(hydroxymethyl)methylenecyclopropane analogues of purine nucleosides: synthesis and antiviral activity
-
Yan Z., Kern E.R., Gullen E., Cheng Y.C., Drach J.C., Zemlicka J. Nucleotides and pronucleotides of 2,2-bis(hydroxymethyl)methylenecyclopropane analogues of purine nucleosides: synthesis and antiviral activity. J. Med. Chem. 2005, 48:91-99.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 91-99
-
-
Yan, Z.1
Kern, E.R.2
Gullen, E.3
Cheng, Y.C.4
Drach, J.C.5
Zemlicka, J.6
-
149
-
-
78650674078
-
Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects
-
Zhou X.J., Pietropaolo K., Chen J., Khan S., Sullivan-Bolyai J., Mayers D. Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects. Antimicrob. Agents Chemother. 2011, 55:76-81.
-
(2011)
Antimicrob. Agents Chemother.
, vol.55
, pp. 76-81
-
-
Zhou, X.J.1
Pietropaolo, K.2
Chen, J.3
Khan, S.4
Sullivan-Bolyai, J.5
Mayers, D.6
|